SUTRO BIOPHARMA, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2019 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Sutro Biopharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2019 to Q3 2024.
  • Sutro Biopharma, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 82M shares, a 35.4% increase year-over-year.
  • Sutro Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 60.2M shares, a 18.6% increase from 2022.
  • Sutro Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 50.7M shares, a 10% increase from 2021.
  • Sutro Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 46.1M shares, a 41.6% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 82M +21.4M +35.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 81.2M +20.9M +34.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 61.5M +2.73M +4.66% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 60.2M +9.42M +18.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-25
Q3 2023 60.6M +8.25M +15.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 60.3M +13.4M +28.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 58.7M +12.2M +26.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 50.7M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-25
Q3 2022 52.3M +6.18M +13.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 47M +841K +1.82% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 46.5M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q3 2021 46.2M +9.28M +25.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 46.1M +16.2M +54.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q3 2020 36.9M +13.9M +60.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 29.9M +6.97M +30.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q3 2019 22.9M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 22.9M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.